Kymera
Kymera is a Massachusetts-based biopharmaceutical company that develops targeted protein degradation therapies for the treatment of cancer and inflammatory diseases.
Business Model:
Revenue: $46M
Employees: 51-200
Industries / Tags:
Detailed Kymera Information
Geographic Data
Address: 200 Arsenal Yards Boulevard
City: Watertown
State: MA
Zip: 02472
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$257M
Raised Total:$454M
Social
Metrics
1,038,457Website Global Rank
31,480Website Monthly Traffic
Twitter Followers
Description
Kymera is a Massachusetts-based biopharmaceutical company that develops targeted protein degradation therapies for the treatment of cancer and inflammatory diseases.
Contact Phone:
+18572855314
Contact Email:
Kymera went public on 8/20/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/20/2020
IPO Valuation:
$863M
Ticker Symbol:
KYMR
IPO Price:
$20/share
Amount Raised:
$174M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
